Karma Biotechnologies

Drug Discovery
Current Valuation
N/A
As of October 21, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Seed Round

$2.8M

Last Funding
Oct 2021

Funding date

Capital Efficiency
N/A

Valuation / Funding

Interested in buying or selling Karma Biotechnologies shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
October 21, 2021Seed Round$2.8MN/A-
Valuation Analysis

Current Valuation Metrics

Karma Biotechnologies is currently valued at N/A as of October 21, 2021.

Explore More Data
Detailed analysis for Karma Biotechnologies

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

Sign up to view Karma Biotechnologies's complete funding timeline, round details, and valuation progression.

What is Karma Biotechnologies Worth in 2026?

Karma Biotechnologies is a leading private company in the Drug Discovery sector. Track Karma Biotechnologies's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Karma Biotechnologies Valuation is Determined

Private company valuations like Karma Biotechnologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.